Modulation of the biological properties of aspirin by formation of a bioorganometallic derivative.
Ott
Ingo
I
Institut für Pharmazie, Freie Universität Berlin, Königin-Luise-Strasse 2+4, 14195 Berlin, Germany. ottingo@zedat.fu-berlin.de
Kircher
Brigitte
B
Bagowski
Christoph P
CP
Vlecken
Danielle H W
DH
Ott
Elisabeth B
EB
Will
Joanna
J
Bensdorf
Kerstin
K
Sheldrick
William S
WS
Gust
Ronald
R
D020533:Angiogenesis Inhibitors / Q000737:chemistry* / Q000494:pharmacology; D000818:Animals; D001241:Aspirin / Q000737:chemistry / Q000494:pharmacology; D053148:Caspase 3 / Q000378:metabolism; D003035:Cobalt / Q000737:chemistry; D051546:Cyclooxygenase 2 / Q000378:metabolism; D052246:Cyclooxygenase 2 Inhibitors / Q000737:chemistry* / Q000494:pharmacology; D009942:Organometallic Compounds / Q000737:chemistry* / Q000494:pharmacology; D017434:Protein Structure, Tertiary; D013329:Structure-Activity Relationship; D053719:Tandem Mass Spectrometry; D015027:Zebrafish
D020533:Angiogenesis Inhibitors; D052246:Cyclooxygenase 2 Inhibitors; D009942:Organometallic Compounds; D003035:Cobalt; D051546:Cyclooxygenase 2; D053148:Caspase 3; D001241:Aspirin